{"schema_version":"1","generated_at":"2026-11-20T09:03:03.299Z","data_as_of":null,"url":"https://www.findmykol.com/kol/barry-zingman","json_url":"https://www.findmykol.com/kol/barry-zingman/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"barry-zingman","name":"Barry Zingman","credential":"MD","specialty":"Infectious Disease","specialty_raw":"Infectious Disease","therapeutic_area":"Infectious Disease","therapeutic_areas":["Infectious Disease"],"city":"Bronx","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"on_file":["npi","orcid","openalex"],"values":"Shown on the profile page to a signed-in account."},"summary":"Barry Zingman is an Infectious Disease physician. OpenAlex indexes 85 publications with 10,749 citations (h-index 24).","overview":null,"focus":{"indications":[],"research_topics":["Infectious Disease"]},"scholarship":{"works_count":85,"cited_by_count":10749,"h_index":24,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":4,"program_years":{"first":2021,"last":null},"rows_total":24,"shown":3,"withheld":21,"rows":[{"payer":"Janssen","program_year":2025,"amount_usd":299184.65,"payment_count":27},{"payer":"Pfizer","program_year":2025,"amount_usd":59104.12,"payment_count":17},{"payer":"ViiV Healthcare Company","program_year":2025,"amount_usd":9036.87,"payment_count":5}],"source":"payments"},"prescribing":{"data_year":2023,"areas_total":7,"areas_shown":3,"areas":[{"area":"Anti-infectives","share_pct":41.8,"classes_total":6,"classes":[{"class":"Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor","setting":"prescribed","share_pct":13,"drugs":[{"name":"Descovy","share_pct":45},{"name":"Triumeq","share_pct":35},{"name":"Zidovudine","share_pct":20}],"max_beneficiaries":null},{"class":"Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor","setting":"prescribed","share_pct":11.9,"drugs":[{"name":"Tivicay","share_pct":100}],"max_beneficiaries":null}]},{"area":"Cardiovascular","share_pct":32.5,"classes_total":5,"classes":[{"class":"Statin","setting":"prescribed","share_pct":9.1,"drugs":[{"name":"Atorvastatin Calcium","share_pct":100}],"max_beneficiaries":11},{"class":"Thiazide diuretic","setting":"prescribed","share_pct":7.1,"drugs":[{"name":"Hydrochlorothiazide","share_pct":100}],"max_beneficiaries":null}]},{"area":"Nervous system","share_pct":11.5,"classes_total":3,"classes":[{"class":"Gabapentinoids","setting":"prescribed","share_pct":4.8,"drugs":[{"name":"Gabapentin","share_pct":100}],"max_beneficiaries":null},{"class":"Nonsteroidal Anti-inflammatory Drug","setting":"prescribed","share_pct":4.3,"drugs":[{"name":"Ibuprofen","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2023,"office_pct":0,"facility_pct":100},"source":"medicare"},"funding":{"award_count":1,"fiscal_years":{"first":2016,"last":2017},"rows_total":2,"shown":2,"withheld":0,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"R21AI122996","title":"Intervention to increase access to PEP to prevent HIV infection among Black MSM","fiscal_year":2017,"amount_usd":"210800","organization":"CITY COLLEGE OF NEW YORK","source_url":"https://reporter.nih.gov/quickSearch/R21AI122996"},{"project":"R21AI122996","title":"Intervention to increase access to PEP to prevent HIV infection among Black MSM","fiscal_year":2016,"amount_usd":"255459","organization":"CITY COLLEGE OF NEW YORK","source_url":"https://reporter.nih.gov/quickSearch/R21AI122996"}],"source":"grants"},"similar":[{"name":"Thomas Walsh","slug":"thomas-walsh","institution":"Cornell University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/thomas-walsh","json_url":"https://www.findmykol.com/kol/thomas-walsh/profile.json"},{"name":"Douglas Richman","slug":"douglas-richman","institution":"University of California San Diego","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/douglas-richman","json_url":"https://www.findmykol.com/kol/douglas-richman/profile.json"},{"name":"Henry Masur","slug":"henry-masur","institution":"National Institutes of Health","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/henry-masur","json_url":"https://www.findmykol.com/kol/henry-masur/profile.json"},{"name":"Vance Fowler","slug":"vance-fowler","institution":"Duke University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/vance-fowler","json_url":"https://www.findmykol.com/kol/vance-fowler/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":21}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}